← Back to catalogue

ALAR Nasal Valve Stent

FDA 510(k)

Class II (US FDA 510(k))

510(k) K151758

by Medtronic Xomed, Inc.

Identifiers

510(k) Number
K151758 FDA 510(k)
FDA Product Code
GAT FDA 510(k)

Classification

Device Class
Class II FDA 510(k)
Legislation / Framework
21 CFR Part 878.5000 FDA 510(k)
Regulation Number
878.5000 FDA 510(k)
Advisory Committee
General, Plastic Surgery FDA 510(k)
FDA Decision
SESE Substantially Equivalent FDA 510(k)

The ALAR Nasal Valve Stent is an elliptically shaped fluoroplastic stent designed to support the lateral nasal wall. It features symmetrically spaced slits for bilateral nostril application and provides support and widening of the alar valve while cartilages scar into their new position.

The device is supplied as a single-use product and is approximately 20mm x 16mm in size. It is authorized under FDA 510(k) clearance with product code GAT and is intended to facilitate nasal breathing in patients with lateral nasal wall insufficiency.

Frequently asked questions

What is the ALAR Nasal Valve Stent designed for?

The ALAR Nasal Valve Stent is designed to support the lateral nasal wall, providing support and widening of the alar valve while cartilages scar into their new position to facilitate nasal breathing in patients with lateral nasal wall insufficiency.

How is the ALAR Nasal Valve Stent supplied?

The device is supplied as a single-use product and is approximately 20mm x 16mm in size, featuring symmetrically spaced slits for bilateral nostril application.

What is the regulatory status of the ALAR Nasal Valve Stent?

The ALAR Nasal Valve Stent is authorized under FDA 510(k) clearance with product code GAT, having been determined to be substantially equivalent to predicate devices.

Is the ALAR Nasal Valve Stent reusable?

No, the ALAR Nasal Valve Stent is supplied as a single-use product and should not be reused for patient safety and effectiveness reasons.

This description and any FAQs above were generated automatically from registry data and have not been verified by the manufacturer or by deviCERTS. Always check the official registry entry and the manufacturer's instructions for use before relying on them. Sources consulted: Effect of alar nasal valve stent on nasal breathing, DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and ..., ALAR Nasal Valve Stent (K151758) — FDA 510(k) | Innolitics

Authorization Coverage (1 country)

Regulatory Authorizations

United States Active

FDA_510K

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Sources (1)

  • FDA 510(k) K151758 24 fields · synced Sep 19, 2026